These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16173323)

  • 1. Prevalence and incidence of diabetes in HIV-infected minority patients on protease inhibitors.
    Salehian B; Bilas J; Bazargan M; Abbasian M
    J Natl Med Assoc; 2005 Aug; 97(8):1088-92. PubMed ID: 16173323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis.
    Echecopar-Sabogal J; D'Angelo-Piaggio L; Chanamé-Baca DM; Ugarte-Gil C
    Int J STD AIDS; 2018 Apr; 29(5):443-452. PubMed ID: 28956700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority patient population.
    Dever LL; Oruwari PA; Figueroa WE; O'Donovan CA; Eng RH
    Ann Pharmacother; 2000 May; 34(5):580-4. PubMed ID: 10852083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of diabetes on CD4 recovery in persons with HIV in an urban clinic in the United States.
    Zuniga JA; Easley KA; Shenvi N; Nguyen ML; Holstad M
    Int J STD AIDS; 2018 Jan; 29(1):63-71. PubMed ID: 28661233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitor-associated QT interval prolongation.
    Hunt K; Hughes CA; Hills-Nieminen C
    Ann Pharmacother; 2011 Dec; 45(12):1544-50. PubMed ID: 22128044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort.
    Brar I; Shuter J; Thomas A; Daniels E; Absalon J;
    J Acquir Immune Defic Syndr; 2007 May; 45(1):66-71. PubMed ID: 17245229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy.
    Barbaro G; Di Lorenzo G; Cirelli A; Grisorio B; Lucchini A; Hazra C; Barbarini G
    Clin Ther; 2003 Sep; 25(9):2405-18. PubMed ID: 14604740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome among HIV infected patients: A comparative cross sectional study in northwestern Nigeria.
    Muhammad FY; Gezawa ID; Uloko A; Yakasai AM; Habib AG; Iliyasu G
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S523-S529. PubMed ID: 28410829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased use of lipid-lowering therapy in patients receiving human immunodeficiency virus protease inhibitors.
    Stein JH; Wu Y; Kawabata H; Iloeje UH
    Am J Cardiol; 2003 Aug; 92(3):270-4. PubMed ID: 12888129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy.
    Galli L; Salpietro S; Pellicciotta G; Galliani A; Piatti P; Hasson H; Guffanti M; Gianotti N; Bigoloni A; Lazzarin A; Castagna A
    Eur J Epidemiol; 2012 Aug; 27(8):657-65. PubMed ID: 22722952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children.
    Viganò A; Aldrovandi GM; Giacomet V; Merlo M; Martelli L; Beretta S; Luraschi P; Rombolà G; Mora S
    Antivir Ther; 2005; 10(8):917-24. PubMed ID: 16430197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?
    Osei K; Rhinesmith S; Gaillard T; Schuster D
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4596-601. PubMed ID: 14557428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time.
    Tripathi A; Liese AD; Jerrell JM; Zhang J; Rizvi AA; Albrecht H; Duffus WA
    Diabet Med; 2014 Oct; 31(10):1185-93. PubMed ID: 24673640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study.
    Guaraldi G; Zona S; Orlando G; Carli F; Stentarelli C; Luzi K; Garlassi E; Menozzi M; Bagni P; Adorni F
    Clin Drug Investig; 2011 Nov; 31(11):759-67. PubMed ID: 21919542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes toward HIV protease inhibitors and medication adherence in an inner city HIV population.
    Demmer C
    AIDS Patient Care STDS; 2003 Nov; 17(11):575-80. PubMed ID: 14746665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women.
    Justman JE; Benning L; Danoff A; Minkoff H; Levine A; Greenblatt RM; Weber K; Piessens E; Robison E; Anastos K
    J Acquir Immune Defic Syndr; 2003 Mar; 32(3):298-302. PubMed ID: 12626890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
    Ledergerber B; Furrer H; Rickenbach M; Lehmann R; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Egger M; Weber R;
    Clin Infect Dis; 2007 Jul; 45(1):111-9. PubMed ID: 17554711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of race and gender with use of antiretroviral therapy among HIV-infected individuals in the Southeastern United States.
    Reif S; Whetten K; Thielman N
    South Med J; 2007 Aug; 100(8):775-81. PubMed ID: 17713302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.